Dr. Fuchs was elected president of the American Association for Cancer Research (AACR) Academy. AACR recognizes and honors extraordinary scientists whose groundbreaking contributions have driven significant innovation and progress in the fight against cancer. Dr. Fuchs was elected to the AACR in 2013, served on its Board of Directors from 2020 to 2023, and elected president of its Academy in 2025.

Svetlana Mojsov, Ph.D., has received numerous prizes for her discovery of GLP-1 and its role as a glucose-dependent inducer of insulin secretion led to the development of new medicines for type 2 diabetes mellitus, and more recently as potent weight-loss drugs that prevent heart attacks. These prizes include: the 2025 Breakthrough Prize,  the Lasker~DeBakey Clinical Medical Research Award, the VinFuture Prize for Innovation with Outstanding Achievements in Emerging Fields, the 2024 Princess of Asturias Award for Technical & Scientific Research, the 2024 Pearl Meister Greengard Prize, the Warren Triennial Prize, the Tang Prize in Biopharmaceutical Science, and the Frontiers of Knowledge Award. She was also named TIME100 Most Influential People of 2024 and Top 10 people who made a difference in science this year by Nature magazine.

Dr. Orange received the John B. Winfield Visiting Scholar Award from the University of North Carolina. This award recognizes an outstanding, nationally known investigator who has made significant contributions to the advancement of research in the fields of rheumatology and arthritis research.

Dr. Rajasethupathy received the inaugural Maximizing Innovation in Neuroscience Discovery Prize (MIND Prize), a new prize presented by the Pershing Square Foundation to recognize and support “next-frontier thinkers” who can uncover a deeper understanding of the brain and cognition, and to yield breakthroughs in neurodegenerative and neurocognitive disorder research.

Dr. Vinogradova was appointed investigator of the Chan Zuckerberg Biohub New York. The Investigator Program provides unrestricted funding for three years to pursue innovative and high-impact research projects that align with the biohub’s mission to harness and bioengineer immune cells for the early detection, prevention, and treatment of a broad spectrum of age-related diseases. Dr. Kivanç Birsoy was also appointed investigator this year.

Dr. Vosshall received the Edward M. Scolnick Prize in Neuroscience for her pioneering work on mosquito olfaction, elucidating the mechanisms by which they find human prey and identify precise sites to target to obtain a blood meal. Her work has implications for the large number of diseases transmitted by mosquito bites. This prize recognizes outstanding advances in the field of neuroscience. She is the fourth Rockefeller scientist to receive this award, joining Drs. Cori Bargmann, Charles Gilbert, and Bruce McEwen who were previously honored.

Dr. Wahba was named a Rita Allen Foundation Scholar in recognition of her work on the non-DNA-based mechanisms by which biological information can be transmitted across generations. This grant is awarded to early-career biomedical scientists.